Risks and Complications of Coronary Angiography: A Comprehensive Review

Coronary angiography and heart catheterization are invaluable tests for the detection and quantification of coronary artery disease, identification of valvular and other structural abnormalities, and measurement of hemodynamic parameters. The risks and complications associated with these procedures relate to the patient’s concomitant conditions and to the skill and judgment of the operator. In this review, we examine in detail the major complications associated with invasive cardiac procedures and provide the reader with a comprehensive bibliography for advanced reading.

[1]  I. Kronzon,et al.  Cholesterol embolization syndrome , 2011, Current opinion in cardiology.

[2]  Act Investigators.  Acetylcysteine for Prevention of Renal Outcomes in Patients Undergoing Coronary and Peripheral Vascular Angiography: Main Results From the Randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT) , 2011, Circulation.

[3]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[4]  M. Tonelli,et al.  Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography , 2011, Circulation.

[5]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[6]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Togni,et al.  Iatrogenic left main coronary artery dissection: incidence, classification, management, and long-term follow-up. , 2010, American heart journal.

[8]  Elizabeth R DeLong,et al.  Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. , 2010, Journal of the American College of Cardiology.

[9]  G. Stone,et al.  Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial , 2010, Circulation. Cardiovascular interventions.

[10]  Regina M. Hardison,et al.  The Bypass Angioplasty Revascularization Investigation 2 Diabetes Randomized Trial of Different Treatment Strategies in Type 2 Diabetes Mellitus With Stable Ischemic Heart Disease: Impact of Treatment Strategy on Cardiac Mortality and Myocardial Infarction , 2009, Circulation.

[11]  M. Jardine,et al.  Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy , 2009, Annals of Internal Medicine.

[12]  I. Moussa,et al.  Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. , 2009, The American journal of cardiology.

[13]  C. Emala,et al.  CLINICAL CONCEPTS AND COMMENTARY , 2009 .

[14]  Andrew A. White,et al.  Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory. , 2009, The Journal of invasive cardiology.

[15]  T. Ryan,et al.  Significantly Improved Vascular Complications Among Women Undergoing Percutaneous Coronary Intervention: A Report From the Northern New England Percutaneous Coronary Intervention Registry , 2009, Circulation. Cardiovascular interventions.

[16]  B. Gersh,et al.  Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. , 2009, Journal of the American College of Cardiology.

[17]  S. Neubauer,et al.  The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. , 2009, International journal of cardiology.

[18]  I. Porto,et al.  Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. , 2009, QJM : monthly journal of the Association of Physicians.

[19]  Subhash Banerjee,et al.  Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery. , 2009, Cardiovascular revascularization medicine : including molecular interventions.

[20]  F. Veglia,et al.  Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.

[21]  M. Velázquez,et al.  Percutaneous Revascularization of Grafts Versus Native Coronary Arteries in Postcoronary Artery Bypass Graft Patients , 2009, Angiology.

[22]  J. Schussler,et al.  Routine Femoral Head Fluoroscopy to Reduce Complications in Coronary Catheterization , 2009, Proceedings.

[23]  A. Elster.  Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial , 2009 .

[24]  M. Leoncini,et al.  Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. , 2008, Journal of the American College of Cardiology.

[25]  J. Baron,et al.  Periprocedural Stroke and Cardiac Catheterization , 2008, Circulation.

[26]  Fang-Shu Ou,et al.  Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[27]  F. Kahl,et al.  Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007. , 2008, JACC. Cardiovascular interventions.

[28]  H. Yip,et al.  Percutaneous coronary intervention for iatrogenic left main coronary artery dissection. , 2008, International journal of cardiology.

[29]  M. Bell,et al.  Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. , 2008, JACC. Cardiovascular interventions.

[30]  J. Ottervanger,et al.  Prognostic value of troponin after elective percutaneous coronary intervention: A meta‐analysis , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[31]  Subhash Banerjee,et al.  Incidence and Treatment of Arterial Access Dissections Occurring during Cardiac Catheterization. , 2008, Journal of interventional cardiology.

[32]  S. Weisbord,et al.  Prevention of contrast-induced nephropathy with volume expansion. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[33]  Furman S. McDonald,et al.  Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[34]  Jun Chen,et al.  Ventricular arrhythmia onset during diagnostic coronary angiography with a 5F or 4F universal catheter. , 2008, Revista espanola de cardiologia.

[35]  S. Pocock,et al.  Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. , 2007, European heart journal.

[36]  Samin K. Sharma,et al.  Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.

[37]  J. Olin,et al.  Contemporary Management of Postcatheterization Pseudoaneurysms , 2007, Circulation.

[38]  J. Kaski,et al.  The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. , 2007, Journal of the American College of Cardiology.

[39]  A. Colombo,et al.  Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies , 2007, Circulation.

[40]  J. Blankenship,et al.  Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention. , 2007, The American journal of cardiology.

[41]  Sidney C. Smith,et al.  Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. , 2007, The American journal of cardiology.

[42]  F. Veglia,et al.  N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. , 2006, The New England journal of medicine.

[43]  Young‐Bae Park,et al.  Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. , 2006, Journal of the American College of Cardiology.

[44]  J. Brinker,et al.  A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. , 2006, Journal of the American College of Cardiology.

[45]  C. Macaya,et al.  Iatrogenic dissection of the ascending aorta following heart catheterisation: incidence, management and outcome. , 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[46]  P. Courtheoux,et al.  Cerebral Microembolism During Cardiac Catheterization and Risk of Acute Brain Injury: A Prospective Diffusion-Weighted Magnetic Resonance Imaging Study , 2006, Stroke.

[47]  Allen J. Taylor,et al.  Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. , 2006, American heart journal.

[48]  W. Little,et al.  Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention 1998–2003 , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[49]  P. Block,et al.  Infection control guidelines for the cardiac catheterization laboratory: Society guidelines revisited , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[50]  E. Fretz,et al.  Vascular communications of the hand in patients being considered for transradial coronary angiography: is the Allen's test accurate? , 2005, Journal of the American College of Cardiology.

[51]  J. Herrmann.  Peri-procedural myocardial injury: 2005 update. , 2005, European heart journal.

[52]  R. Solomon.  The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. , 2005, Kidney international.

[53]  M. Hong,et al.  Neurological complications following percutaneous coronary interventions (a report from the 2000-2001 New York State Angioplasty Registry). , 2005, The American journal of cardiology.

[54]  K. Lackner,et al.  Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. , 2005, Radiology.

[55]  E. Topol,et al.  Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. , 2005, The American journal of cardiology.

[56]  R. Shaw,et al.  Angiographic predictors of femoral access site complications: Implication for planned percutaneous coronary intervention , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[57]  Z. Turi.  Optimizing vascular access: Routine femoral angiography keeps the vascular complication away , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[58]  Christopher M. Thompson,et al.  Fluoroscopic localization of the femoral head as a landmark for common femoral artery cannulation † , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[59]  I. Jang,et al.  When heparins promote thrombosis: review of heparin-induced thrombocytopenia. , 2005, Circulation.

[60]  A. Yeung,et al.  Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. , 2005, Journal of the American College of Cardiology.

[61]  D. Ardissino,et al.  Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. , 2005, European heart journal.

[62]  D. Greenwood,et al.  Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention , 2004, Circulation.

[63]  D. Ramsdale,et al.  Bacteremia following complex percutaneous coronary intervention. , 2004, The Journal of invasive cardiology.

[64]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[65]  S. Pocock,et al.  Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. , 2004, Journal of the American College of Cardiology.

[66]  A. Levin,et al.  A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. , 2004, American heart journal.

[67]  V. Pasceri,et al.  Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary Intervention: Results From the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) Study , 2004, Circulation.

[68]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[69]  T. Risler,et al.  What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? , 2004, Clinical nephrology.

[70]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[71]  K. Harjai,et al.  Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. , 2004, Journal of the American College of Cardiology.

[72]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[73]  J. Sanderson,et al.  Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[74]  K. Harjai,et al.  Characteristics of cerebrovascular accidents after percutaneous coronary interventions. , 2004, Journal of the American College of Cardiology.

[75]  S. Mehta,et al.  Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. , 2004, The American journal of cardiology.

[76]  A. Prakash,et al.  Predictors of troponin elevation after percutaneous coronary intervention. , 2004, The American journal of cardiology.

[77]  V. Garovic,et al.  Contrast nephropathy after coronary angiography. , 2004, Mayo Clinic proceedings.

[78]  M. Müllner,et al.  Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. , 2004, JAMA.

[79]  Samin K. Sharma,et al.  Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. , 2004, The American journal of cardiology.

[80]  Christopher M. Thompson,et al.  Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study. , 2003, The Journal of invasive cardiology.

[81]  G. Stone,et al.  Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. , 2003, JAMA.

[82]  R. Califf,et al.  The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results. , 2003, The Journal of invasive cardiology.

[83]  Walter R Wilson,et al.  Nonvalvular Cardiovascular Device–Related Infections , 2003, Circulation.

[84]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[85]  G. Marenzi,et al.  The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.

[86]  F. Markowetz,et al.  Acetylcysteine for prevention of contrast nephropathy: meta-analysis , 2003, The Lancet.

[87]  T. Bashore,et al.  Cholesterol emboli after invasive cardiac procedures. , 2003, Journal of the American College of Cardiology.

[88]  M. Keane,et al.  Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. , 2003, European heart journal.

[89]  B. Nallamothu,et al.  Prognostic implication of troponin I elevation after percutaneous coronary intervention. , 2003, The American journal of cardiology.

[90]  A. Takeshita,et al.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. , 2003, Journal of the American College of Cardiology.

[91]  P. Aspelin,et al.  Nephrotoxic effects in high-risk patients undergoing angiography. , 2003, The New England journal of medicine.

[92]  D. Kovacevich,et al.  Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[93]  D. Walters,et al.  Heparin-induced thrombocytopenia: a common complication in cardiac transplant recipients. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[94]  Rosario V. Freeman,et al.  Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. , 2002, The American journal of cardiology.

[95]  J. Moses,et al.  Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin‐induced thrombocytopenia , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[96]  P. Moore,et al.  Adverse drug reactions to local anesthesia. , 2002, Dental clinics of North America.

[97]  C. White,et al.  Percutaneous management of access site complications , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[98]  N. Weissman,et al.  Stroke Complicating Percutaneous Coronary Interventions: Incidence, Predictors, and Prognostic Implications , 2002, Circulation.

[99]  C. Perings,et al.  Incidence and clinical outcome of iatrogenic femoral arteriovenous fistulas: implications for risk stratification and treatment. , 2002, Journal of the American College of Cardiology.

[100]  V. Hasselblad,et al.  Prognostic significance of elevated troponin I after percutaneous coronary intervention. , 2002, Journal of the American College of Cardiology.

[101]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[102]  M. Webster,et al.  Meralgia paresthetica: An unusual complication of cardiac catheterization via the femoral artery , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[103]  William S Weintraub,et al.  Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000. , 2002, Journal of the American College of Cardiology.

[104]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[105]  E. Elinav,et al.  Improvement in cholesterol emboli syndrome after iloprost therapy , 2002, BMJ : British Medical Journal.

[106]  Douglas Losordo,et al.  Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). , 2002, The American journal of cardiology.

[107]  A. Serra,et al.  Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.

[108]  J. Delcán,et al.  Bloodstream infections after invasive nonsurgical cardiologic procedures. , 2001, Archives of internal medicine.

[109]  E. Cook,et al.  Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. , 2001, JAMA.

[110]  R. Califf,et al.  Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. , 2001, JAMA.

[111]  F. Leclercq,et al.  Transcranial Doppler Detection of Cerebral Microemboli during Left Heart Catheterization , 2001, Cerebrovascular Diseases.

[112]  M A Hlatky,et al.  American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001 .

[113]  J. Jenkins,et al.  Treatment of femoral artery pseudoaneurysm with percutaneous thrombin injection , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[114]  D. DeLong,et al.  Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. , 2001, AJR. American journal of roentgenology.

[115]  G. Graziani,et al.  Corticosteroids in Cholesterol Emboli Syndrome , 2001, Nephron.

[116]  D. Kereiakes,et al.  Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[117]  J. Tanguay,et al.  Complications of cardiac catheterization in the current era: A single‐center experience , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[118]  S. Kaul,et al.  Task Force on Clinical Expert Consensus Documents Endorsed by the American Heart Association and the , 2022 .

[119]  R. Califf,et al.  Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. , 2000, The Journal of invasive cardiology.

[120]  J. Cronan,et al.  Percutaneous injection of thrombin for the treatment of pseudoaneurysms after catheterization: an alternative to sonographically guided compression. , 2000, AJR. American journal of roentgenology.

[121]  M. Leon,et al.  Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. , 2000, The American journal of cardiology.

[122]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[123]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[124]  D. Scheinert,et al.  Treatment of Catheter-Induced Iliac Artery Injuries with Self-Expanding Endografts , 2000, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[125]  R. Erbel,et al.  Infectious complications related to the use of the Angio‐Seal hemostatic puncture closure device , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[126]  M. Bertrand,et al.  Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: A multicenter, randomized, double-blind study. Visipaque in Percutaneous Tr , 2000, Circulation.

[127]  P. Parfrey,et al.  Contrast nephropathy. , 2000, Journal of the American Society of Nephrology : JASN.

[128]  F. Fabris,et al.  Heparin-induced thrombocytopenia. , 2000, Haematologica.

[129]  D. Steed,et al.  Thrombin injection versus compression of femoral artery pseudoaneurysms. , 1999, Journal of vascular surgery.

[130]  A. Nicolaides,et al.  Treatment of an iatrogenic femoral artery pseudoaneurysm with percutaneous duplex-guided injection of thrombin. , 1999, Circulation.

[131]  M. Morice,et al.  Emergency coronary artery bypass surgery following coronary angioplasty and stenting: Results of a French multicenter registry , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[132]  W. Voelker,et al.  Risiko der invasiven Diagnostik mit retrograder Sondierung des linken Ventrikels bei Patienten mit erworbener Aortenklappenstenose , 1999, Zeitschrift für Kardiologie.

[133]  R. Ensslen,et al.  A randomized trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on abrupt vessel closure and ischemic complications after coronary angioplasty. , 1999, Journal of the American College of Cardiology.

[134]  K. Karsch,et al.  [Risk of invasive diagnosis with retrograde catheterization of the left ventricle in patients with acquired aortic valve stenosis]. , 1999, Zeitschrift fur Kardiologie.

[135]  C. Grines,et al.  Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. , 1998, Journal of the American College of Cardiology.

[136]  C. Bladin,et al.  Transcranial Doppler detection of microemboli during percutaneous transluminal coronary angioplasty. , 1998, Stroke.

[137]  R. Califf,et al.  Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide , 1998 .

[138]  H. Lachmann,et al.  Improvement in renal cholesterol emboli syndrome after simvastatin , 1998, The Lancet.

[139]  R. Califf,et al.  Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. , 1998, Journal of the American College of Cardiology.

[140]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[141]  A. Suryaprasad,et al.  Incidence of Atheroembolic Renal Failure After Coronary Angiography , 1997, Angiology.

[142]  P. Coste,et al.  Comparison of 6F with 7F and 8F guiding catheters for elective coronary angioplasty: results of a prospective, multicenter, randomized trial. , 1997, American heart journal.

[143]  J. J. Griffin,et al.  A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. , 1997, Journal of the American College of Cardiology.

[144]  P. Koudstaal,et al.  Heparin‐induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases , 1997, British journal of haematology.

[145]  A. Keren,et al.  Frequency and distribution of atherosclerotic plaques in the thoracic aorta as determined by transesophageal echocardiography in patients with coronary artery disease. , 1997, The American journal of cardiology.

[146]  M. Rudnick,et al.  Contrast media-associated nephrotoxicity. , 1996, Current opinion in nephrology and hypertension.

[147]  R. Califf,et al.  Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). , 1995, Journal of the American College of Cardiology.

[148]  E. Becker,et al.  A prospective randomized trial comparing the benefits and limitations of 6Fr and 8Fr guiding catheters in elective coronary angioplasty: clinical, procedural, angiographic, and economic end points. , 1995, Journal of interventional cardiology.

[149]  Incidence of Pseudoaneurysm after Diagnostic and Therapeutic Angiography , 1995 .

[150]  P. Reddy,et al.  Predisposing risk factors and natural history of acute neurologic complications of left-sided cardiac catheterization. , 1995, The American journal of cardiology.

[151]  M. Savage,et al.  Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia. , 1995, Catheterization and cardiovascular diagnosis.

[152]  E. Minar,et al.  Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. , 1995, Radiology.

[153]  F. Heupler,et al.  Systemic anaphylactoid reactions to lodinated contrast media during cardiac catheterization procedures: Guidelines for prevention, diagnosis, and treatment , 1995 .

[154]  F. Heupler,et al.  Systemic anaphylactoid reactions to iodinated contrast media during cardiac catheterization procedures: guidelines for prevention, diagnosis, and treatment. Laboratory Performance Standards Committee of the Society for Cardiac Angiography and Interventions. , 1995, Catheterization and cardiovascular diagnosis.

[155]  E. Halpern,et al.  Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. , 1995, Kidney international.

[156]  S. Ellis,et al.  Increased Coronary Perforation in the New Device Era: Incidence, Classification, Management, and Outcome , 1994, Circulation.

[157]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[158]  E. Wittbrodt,et al.  Prevention of Anaphylactoid Reactions in High-Risk Patients Receiving Radiographic Contrast Media , 1994, The Annals of pharmacotherapy.

[159]  J. Hirshfeld,et al.  A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use. , 1994, Circulation.

[160]  Robert R. L. Smith,et al.  Results and Complications , 1994 .

[161]  L. Hillis,et al.  Vasovagal reactions in the cardiac catheterization laboratory. , 1994, The American journal of cardiology.

[162]  W. Laskey,et al.  Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography & Interventions. , 1993, Catheterization and cardiovascular diagnosis.

[163]  W. Reeves,et al.  Deep venous thrombosis and pulmonary embolism following cardiac catheterization. , 1993, Catheterization and cardiovascular diagnosis.

[164]  M. Leon,et al.  Vascular Complications After Balloon and New Device Angioplasty , 1993, Circulation.

[165]  B. Barrett,et al.  Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. , 1993, Radiology.

[166]  D. Baim,et al.  A prospective study of the clinical outcome of femoral pseudoaneurysms and arteriovenous fistulas induced by arterial puncture. , 1993, Journal of vascular surgery.

[167]  P. Parfrey,et al.  A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. , 1992, The New England journal of medicine.

[168]  N. Powe,et al.  Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. , 1992, The New England journal of medicine.

[169]  D. Baim,et al.  Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. , 1992, Catheterization and cardiovascular diagnosis.

[170]  O. Isom,et al.  Effects of shaving methods and intraoperative irrigation on suppurative mediastinitis after bypass operations. , 1992, The Annals of thoracic surgery.

[171]  D. Swanson,et al.  Acute reactions to intravascular contrast media: types, risk factors, recognition, and specific treatment. , 1991, AJR. American journal of roentgenology.

[172]  D A Clark,et al.  Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). , 1991, Catheterization and cardiovascular diagnosis.

[173]  M. Mooney,et al.  Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. , 1991, The American journal of cardiology.

[174]  D. Lang,et al.  Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. , 1991, Annals of internal medicine.

[175]  J. Fehrenbacher,et al.  Septic complications after cardiac catheterization and percutaneous transluminal coronary angioplasty. , 1991, Journal of vascular surgery.

[176]  J. P. Johns,et al.  Spontaneous thrombosis of iatrogenic femoral artery pseudoaneurysms: documentation with color Doppler and two-dimensional ultrasonography. , 1991, Journal of vascular surgery.

[177]  A. Schoenfeld,et al.  Radiocontrast-associated renal dysfunction: a comparison of lower-osmolality and conventional high-osmolality contrast media. , 1991, AJR. American journal of roentgenology.

[178]  R E Vlietstra,et al.  A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography. , 1991, Journal of the American College of Cardiology.

[179]  M. Winniford,et al.  A prospective study of the incidence and natural history of femoral vascular complications after percutaneous transluminal coronary angioplasty. , 1991, Journal of vascular surgery.

[180]  R. B. Smith,et al.  Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. , 1990, Journal of vascular surgery.

[181]  J. Carroll,et al.  Cardiac catheterization in the patient with history of allergy to local anesthetics. , 1990, Catheterization and cardiovascular diagnosis.

[182]  R. Clauss,et al.  Incidence and results of arterial complications among 16,350 patients undergoing cardiac catheterization. , 1989, Journal of vascular surgery.

[183]  L. Laslett,et al.  Wearing of caps and masks not necessary during cardiac catheterization. , 1989, Catheterization and cardiovascular diagnosis.

[184]  L. Hillis,et al.  Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. , 1989, The American journal of medicine.

[185]  A. Pichard,et al.  Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. , 1989, Catheterization and cardiovascular diagnosis.

[186]  K. Hammermeister,et al.  Complications of cardiac catheterization and angiography in patients with valvular heart disease. VA Cooperative Study on Valvular Heart Disease. , 1989, Catheterization and cardiovascular diagnosis.

[187]  L. Ong,et al.  Local infection after percutaneous transluminal coronary angioplasty: relation to early repuncture of ipsilateral femoral artery. , 1989, Catheterization and cardiovascular diagnosis.

[188]  J. Kisslo,et al.  Utility of Doppler color flow imaging for identification of femoral arterial complications of cardiac catheterization. , 1989, American heart journal.

[189]  D. Baim,et al.  Current complications of diagnostic and therapeutic cardiac catheterization. , 1988, Journal of the American College of Cardiology.

[190]  K. Bolz.  [Complications of angiography]. , 1988, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[191]  N. Wolf,et al.  Effect of calcium-binding additives on ventricular fibrillation and repolarization changes during coronary angiography. , 1987, Journal of the American College of Cardiology.

[192]  Hildreth Ea.  Anaphylactoid reactions to iodinated contrast media. , 1987 .

[193]  E. A. Hildreth.  Anaphylactoid reactions to iodinated contrast media. , 1987, Hospital practice.

[194]  R. Patterson,et al.  Emergency administration of radiocontrast media in high-risk patients. , 1986, The Journal of allergy and clinical immunology.

[195]  S. Kelsey,et al.  Acute coronary events associated with percutaneous transluminal coronary angioplasty. , 1984, The American journal of cardiology.

[196]  S. Kelsey,et al.  Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry , 1983, Circulation.

[197]  J. Kennedy.  Complications associated with cardiac catheterization and angiography. , 1982, Catheterization and cardiovascular diagnosis.

[198]  G. Myers,et al.  Cimetidine (Tagamet) combined with steroids and H1 antihistamines for the prevention of serious radiographic contrast material reactions. , 1981, Catheterization and cardiovascular diagnosis.

[199]  J. W. Kennedy,et al.  Complications of Coronary Arteriography from the Collaborative Study of Coronary Artery Surgery (CASS) , 1979, Circulation.

[200]  R. Lambert,et al.  Cholesterol embolization: a complication of angiography. , 1978, Archives of internal medicine.

[201]  M. P. Judkins,et al.  Prevention of Complications of Coronary Arteriography , 1974, Circulation.

[202]  H L Abrams,et al.  The Complications of Coronary Arteriography , 1973, Circulation.

[203]  C. Wooley.  COOPERATIVE STUDY ON CARDIAC CATHETERIZATION , 1969 .

[204]  E. Braunwald,et al.  Cooperative study on cardiac catheterization. Total population studied, procedures employed, and incidence of complications. , 1968, Circulation.